News Article | November 4, 2016
With the growth of the elderly population and increase in minimally invasive procedures, the number of medical instruments that need to be reprocessed grows rapidly, which drives the rising demand for sterilization equipment. Physical sterilizers to conduct steam sterilization dominate the sterilization equipment market, due to their effective microbicidal features, strong penetration, fast cycle time, and affordable price. With the development of complex surgical instruments, more heat- and moisture-sensitive devices have been used in surgical procedures. Consequently, chemical sterilizers using low-temperature sterilization technology have consistently gained acceptance. Among all chemical sterilizers, hydrogen peroxide sterilizers are the most popular devices in hospitals. The market for hydrogen peroxide sterilizers is growing steadily. However, various regulations exist that restrict the use of ethylene oxide, hydrogen peroxide, and other sterilants in hospitals, which will limit the penetration of the chemical sterilization technology. This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed and pipeline products, current and emerging players, as well as market outlooks in the APAC market. The report identifies the unmet needs in the market while providing an understanding of physicians’ perceptions in using and evaluating the adoption of different types of sterilization devices. *This is an on-demand report and will be delivered within 4 working days (excluding weekends) of the purchase. - What is the current and future sterilization equipment market outlook in APAC? What trends are affecting the APAC market? - What is the competitive landscape and market share of major players in the sterilization equipment space in APAC? - What are the key, high growth markets that sterilization equipment manufacturers should expand into? Which market segments are growing the fastest? - What are the unmet needs with the sterilization equipment devices currently on the market? How will emerging technologies fulfill these unmet needs? - What is physician perception and market outlook of sterilization equipment devices? - What are the challenges and barriers that have hindered widespread adoption of sterilization equipment devices? - “What Do Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information. 1 Table of Contents 1.1 List of Tables 1.2 List of Figures 2 Introduction 2.1 Catalyst 2.2 Technology Overview 2.2.1 Physical Sterilizers 2.2.2 Chemical Sterilizers 2.2.3 Other Sterilization Methods 2.3 Related Reports 3 Market Access 3.1 Regulatory 3.2 Recalls and Prodcut Safety Issues 3.3 Key Mergers, Acquisitions, and Partnerships 4 Unmet Needs 4.1 Product Safety 4.2 Technology Innovation 4.3 The Risk to Patient Safety 4.4 Limited Consideration of Reprocessing 4.5 Education and Training 5 Competitive Assessment 5.1 Major Players 5.1.1 3M Health Care Ltd. 5.1.2 Advanced Sterilization Products Services Inc. 5.1.3 Andersen Products 5.1.4 Antonio Matachana,S.A. 5.1.5 Baumer S.A. 5.1.6 Belimed Sauter AG 5.1.7 BMM Weston Ltd. 5.1.8 Getinge AB 5.1.9 Korea Miura Co., LTD. 5.1.10 LTE Scientific Ltd. 5.1.11 Munchener Medizin Mechanik GmbH 5.1.12 Steris Plc 5.1.13 Tuttnauer USA Co. Ltd. 5.1.14 Tso3 Inc. 5.1.15 Xenex Disinfection Services LLC 5.2 Emerging Players 5.2.1 Sterilucent, Inc. 5.3 Marketed Products Assessent 5.3.1 Physical Sterilizers 5.3.2 Chemical Sterilizers 5.3.3 Ultraviolet Disinfection Systems 5.4 Pipeline Assessment 5.5 Company Share Analysis 5.5.1 APAC 6 Market Outlooks 6.1 Procedure Trends 6.1.1 Technology Preference 6.1.2 Consumables 6.1.3 Outsourcing 6.2 Market Drivers and Barriers 6.2.1 Driver: Aging Populations 6.2.2 Driver: Increasing Number of Minimally Invasive Procedures 6.2.3 Driver: Technological Innovations 6.2.4 Driver: Favorable Government Healthcare Policy 6.2.5 Barrier: Safety Concerns 6.2.6 Barrier: Greater Adoption of Single-use Instruments 6.2.7 Barrier: Economic Climate 6.3 Market Outlooks by Segment 6.3.1 By Region 6.4 Market Outlooks by Geography 6.4.1 Japan 6.4.2 China 6.4.3 India Continued……. For more information or any query mail at [email protected] Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
News Article | December 20, 2016
DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Chlorobenzene Market Size, Share, Development, Growth and Demand Forecast to 2022" report to their offering. Chlorobenzene is a colorless and flammable aromatic organic compound. It is also known as phenyl chloride or benzene chloride. It is produced by benzene chlorination in the presence of catalyst and acids, such as anhydrous aluminum chloride, ferric chloride and sulfur chloride. The global chlorobenzene market is witnessing growth, owing to its large volume applications in chemical industry. There are several types of chlorobenzene, such as monochlorobenzene, orthodichlorobenzene, paradichlorobenzene, trichlorobenzene, tetrachlorobenzene and hexachlorobenzene. Some of the players operating in the global chlorobenzene market include Beckmann-Kenko GmbH, Jiangsu Yangnong Chemicals Group Co., Ltd., Meryer (Shanghai) Chemical Technology Co., Ltd., J&K Scientific Ltd, China Petrochemical Corporation, Kureha Corporation, Applichem GmbH and Chemada Fine Chemicals. For more information about this report visit http://www.researchandmarkets.com/research/22cm2g/global
News Article | November 7, 2016
Gel imaging systems, also known as gel documentation systems is a revolutionized medical equipment which performs the function of imaging, documentation or recording of stained DNA and proteinon a high tech digital platform. Gel imaging systems is a combination of different component such as an imaging system, a computer, a light source, analysis software and a printer. For instance, G:BOX F3 is an entry level gel documentation system manufactured by Syngene fluorescence and visible applications. The systems works with GeneSys software which handles hundreds of application protocol and functional control. The product even have high resolution camera coupled with motor driven zoom lens, which is capable of giving high quality gel images along with the spatial resolution. Many other companies are engaged in manufacturing of gel imaging systems such as Thermo Fisher Scientific, BIOTEC-FISCHER, UVP LLC, Cleaver Scientific Ltd., and Bio-Rad Laboratories, Inc. Gel imaging technology has come a long way since its inception, where the technicians used to prefer instant cameras. It has replaced the traditional approach of gel analysis and documentation owing to its better dynamic range, faster exposure and higher efficiency. Moreover, other tools such as signal saturation and automated features offers user friendly experience of gel documentation to new technicians. In terms of reliability, functionality, and affordability, these devices has improved enormously and today’s gel imaging equipment’s illustrate this development. Growing clinical research industry and increasing use of molecular biology techniques into pathology laboratory practices are expected to drive the growth of gel documentation systems market. Currently, the use of advance techniques such as Western blot technique, and DNA diagnostics has increased tremendously, which in return generates need for automated and advance gel documentation systems. Additionally, companies are also focusing on the approval and product launch of gel documentation systems owing to substantial growth in clinical research and drug development industry. Recently, Viewpoint Laboratories, LLC, has launched a new gel documentation system i.e. ZIG-gel Classic, which provides imaging power of an 18 MP, 10x optical zoom camera. This product is expected to fulfill the need of consumer looking for the high image resolution along with the conventional form factor particularly for research labs and life science educator labs. Such ongoing product development and launch by the leading companies are expected to drive the growth of gel documentation systems market. The global market for gel documentation is segmented on the basis of product type, component, application and geography. Based on application, the global gel documentation systems market is divided into following: On the basis of component, the global gel documentation system market is segmented as, Based on application, the global gel documentation systems market is divided into following: Development of advanced but low cost gel documentation systems will pave the road for new entrants. The upcoming research and drug development activities will open a new avenue and extraordinary opportunities for gel documentation systems manufacturing companies. The cost of gel documentation systems is currently high owing to incorporation of advanced technologies and complex consumer’s requirements. However, many Chinese manufacturers are now coming up with the low cost and low resolution gel imaging devices. Thus, the price of these devices is expected to decrease as compared to the branded products in coming years. Geographically, the global gel documentation system market is segmented into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific Excluding Japan, Japan, Middle East and Africa. Among all the regions, North America will continue to lead the global market for gel documentations systems market due to high demand for research and development activities. Europe market is expected to account for second largest share in global market primarily due to high adoption of gel documentation systems which is expected to fuel the market growth. Asian companies are competing on the basis of price and research activities. Hence, the Asia Pacific gel documentation systems market is expected to witness fastest growth in overall market over the forecast period. Key players operating in the global gel documentation systems market are Syngene, Bio-Rad Laboratories, Thermo Fisher Scientific, Inc., UVP LLC, eikonix Ltd, Viewpoint Laboratories, TBG Biotechnology Corp and others
News Article | October 26, 2016
The University of Strathclyde has emerged as the winner of Europe's biggest space technology innovation competitions, that recognise great ideas with commercial potential. Strathclyde was the overall and UK regional winner of the European Satellite Navigation Competition (ESNC) for a low-cost early detection system for UAVs (Unmanned Aerial Vehicles). Out of a field of over 500 entries from 17 countries, five UK finalists came home from the ESNC awards in Madrid with an award and the top prize of €10,000 to invest in their technology. Other UK winning ideas include a smartphone sleeve to enable access to the Galileo Public Regulatory Service (an encrypted navigation service for governmental authorised users), a UK wildfire monitoring service and a smart navigation device for cyclists. Dr Carmine Clemente, Domenico Gaglione and Christos Ilioudis from the Sensor Signal Processing and Security Labs at Strathclyde Space Institute, developed the idea with support from the Scottish Centre of Excellence in Satellite Applications (SoXSA). Dr Clemente said: "It is incredible to have won first place, especially seeing the calibre of entries here tonight. The competition is an exciting opportunity for us to accelerate our idea to a market-ready application." Dr Malcolm Macdonald, Director of SoXSA, said: "This award is further evidence that Strathclyde is a leading international technological university at the heart of the thriving and rapidly growing Scottish space sector, and is due recognition for the work that Carmine and his team have been doing." The project is a 'silent lookout' system that uses low-cost sensors and satellite navigation technology for the early detection of UAVs, addressing growing concerns over public safety, security and privacy. The team is working on a passive radar system using Global Navigation Satellite System (GNSS) signals for micro-UAV detection, classification and tracking. The Passive Bi-Static Radar (PBR) works by exploiting sources of electromagnetic energy to accomplish radar tasks such as target detection, parameter estimation and recognition. Whilst collision and crash avoidance is of paramount concern, authorities are also concerned about UAVs available in the leisure market being used to cause large-scale civilian casualties. The 'silent lookout' system could be deployed as a perimeter around a football stadium or open-air concert venue with the sensors creating a 'detection arc' at a distance that would allow authorities enough time to take appropriate action. Stuart Martin, CEO, Satellite Applications Catapult and Chair of the UK judging panel said: "This is a great result and reflects the quality of innovation in satellite applications coming out of the UK today. The winning ideas won the backing of experts from across the European satellite sector who will be offering significant support to help the teams realise their ambitions and build successful businesses." Nottingham Scientific Ltd and QinetiQ - Winner, BMVI* Special Prize: PRS applications - reliable services for a secure digital society. The world is increasingly reliant on positon and time data from satellite navigation systems, but the threat to the use of this technology from interference and spoofing is growing rapidly. The new Public Regulatory Service (PRS) provided by Europe's Galileo satellite navigation system will enable governments to be more resilient to global satellite navigation system threats. Nottingham Scientific Ltd (NSL) in partnership with QinetiQ have been awarded the PRS prize for their innovative mobile phone 'GRIPPA' sleeve which has been specifically developed to help government authorised users access the PRS more easily and securely for critical applications. Potential customers for PRS include the emergency services, critical national infrastructure, law enforcement, public security and defence operations. Dr Gail Millin-Chalabi, Dr Ioanna Tantanasi and Dr Stefania Amici from the School of Environment, Education and Development (SEED) at the University of Manchester, won first place in the Copernicus Masters Sustainable Living Challenge, with EnviroSAR, a UK wildfire monitoring service that uses satellite Earth observation data. Fire and Rescue Services spend around £55 million every year fighting UK wildfires that damage unique habitats, such as the UK's moorlands and heathlands, and discolour drinking water supplies creating clean-up costs for water companies. The EnviroSAR service will help to understand patterns of UK wildfires, target land management, peat restoration, reseeding and reduce water discolouration and its associated costs. The EnviroSAR monitoring and detection tool is based on a new analysis technique developed by the team to interpret Synthetic Aperture Radar and optical data from Sentinel Earth Observation satellites to deliver 'burnt-area' imagery. One of the key barriers to cycling for many city-dwellers is poor knowledge of safe, cycle-friendly routes. Blubel is a smart navigation device that can intuitively guide cyclists, using a mix of sounds and lights along the cycle-friendly routes. The device enables exchange of information between the cyclists building social navigation that is dynamic to the cyclists' preferable routes and adapts to the ever-changing conditions on the roads in real-time. The UK ESNC is managed by the Satellite Applications Catapult with the support of the UK Space Agency, Innovate UK, Marks & Clerk Intellectual Property Services, Airbus Defence and Space, the Science and Technology Facilities Council and the ESA Business Incubation Centre (ESA BIC) Harwell, Ashby House, the Royal Institute of Navigation and Allen, Everest and Associates. Catherine Mealing-Jones, Director of Growth at the UK Space Agency said: "We rock at innovation here in the UK. All the winners demonstrate the fantastic potential for innovators to take advantage of the opportunities presented by satellite technology. The competition itself helps to showcase and ultimately grow their ideas as businesses. The UK is proud to have such innovators and hope that they inspire others to realise what they stand to gain by having a go." Andy Proctor, Innovation Lead for Satellite Technology at Innovate UK said: "The University of Strathclyde's innovative concept in the use of GNSS signals has great potential to be a step-change in low-cost monitoring, and a real example of why Innovate UK sponsors the ESNC. As a judge, it was clear that this idea has great potential to move quickly from its research roots to a revenue potential, and winning the prize will enable this team to take the next steps on this path." "I'm delighted that the University of Strathclyde team have achieved this well deserved recognition. Their technically innovative use of GNSS signals as part of a Passive Bi-Static Radar System potentially provides an exciting new method in the early detection of micro UAVs." Tim Watkin, Partner at Marks & Clerk, a leading firm of intellectual property (IP) experts that sponsors the competition, said: "Year after year, ESNC attracts entries of the highest quality, that display real innovative flair. The team from Strathclyde were particularly impressive, and we look forward to supporting them with intellectual property advice as they work towards bringing their concept to market." "STFC is committed to innovation and has supported the ESNC for many years, evaluating entries and encouraging applicants to enter the ESA Business Incubation Centres. We were highly impressed by the Strathclyde team's innovative 'alternative' use of GNSS and the commercial potential that came with it."
News Article | November 8, 2016
— Global Autoclave Industry is the new market research report now available with DeepResearchReports.com Complete report on Autoclave market spread across 121 pages, profiling 18 companies and supported with 98 tables and figures is now available @ http://www.deepresearchreports.com/208911.html . The global Autoclave market 2016 research is a professional and in-depth study on the current state of the industry and provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Autoclave market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The report focuses on global major leading industry players of Autoclave market providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Autoclave market development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. With 98 tables and figures helping analyze worldwide Autoclave market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Companies profiled and studied for this Autoclave market report include Astell Scientific Ltd., Benchmark Scientific Inc., MELAG Medizintechnik oHG, Panasonic Biomedical Sales Europe B.V., Tuttnauer Europe B.V., Advanced Sterilization Products (ASP), BMM Weston, Cisa Production, Getinge Group, Matachana, Priorclave, STERIS and Thermo Scientific. Order a copy of Global Autoclave Market Report 2016 @ http://www.deepresearchreports.com/contacts/purchase.php?name=208911 . 1 Autoclave Overview 2 Global Autoclave Market Competition by Manufacturers 3 Global Autoclave Market Analysis by Type and Applications 4 Global Autoclave Manufacturers Analysis 5 Global Autoclave Market Analysis by Regions 2011-2020 6 Autoclave Technology and Development Trend 7 Research Findings and Conclusion A discount can be asked before order a copy of Autoclave market report @ http://www.deepresearchreports.com/contacts/inquiry.php?name=208911 . About Us: Deep Research Reports is digital database of syndicated market reports for global and China industries. These reports offer competitive intelligence data for companies in varied market segments and for decision makers at multiple levels in these organizations. We provide 24/7 online and offline support to our customers. For more information, please visit http://www.deepresearchreports.com/208911.html
News Article | November 9, 2016
The report on global influenza diagnostics market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the period 2015-2022. The market size in terms of revenue (USD MN) is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints). The Influenza Diagnostics Market Research Report provides forecast and estimates for each application in terms of Market Size, Share, Trend and Growth during the study period 2015-2022. A glimpse of the major drivers and restraints affecting this market is mentioned below: A. Drivers > Rising geriatric population > Growing prevalence of chronic diseases > Increasing government initiatives to counter influenza > Emergence of technologically advanced influenza diagnostics tests B. Restraints > Product safety and high cost of development Get Free Sample Copy of this Report @ http://www.decisiondatabases.com/contact/download-sample-11266 Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography for the study period 2015-2022. The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities. The report classifies the market into different segments based on test type and end-use. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market. The report also covers the complete competitive landscape of the worldwide market with company profiles of key players such as Becton, Dickinson and Company, Quidel Corporation, Roche, Sekisui Diagnostics, LLC, SA Scientific Ltd., Meridian Bioscience, Inc., Thermo Fisher Scientific, 3M Health Care, and Alere. A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments. 1. By Test Type: > RIDT > RT-PCR > Cell Culture > Others 2. By End-Use: > Hospitals > POCT > Laboratories 3. By Geography: > North America (NA) > Europe (EU) > Asia Pacific (APAC) > Latin America (LA) > Middle East & Africa (MEA) 1. INTRODUCTION 2. EXECUTIVE SUMMARY 3. MARKET ANALYSIS 4. INFLUENZA DIAGNOSTICS MARKET ANALYSIS BY TEST TYPE 5. INFLUENZA DIAGNOSTICS MARKET ANALYSIS BY END-USE 6. INFLUENZA DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY 7. COMPETITIVE LANDSCAPE OF THE INFLUENZA DIAGNOSTICS COMPANIES 8. COMPANY PROFILES OF THE INFLUENZA DIAGNOSTICS INDUSTRY DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains. Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.
News Article | November 16, 2016
St. Vincent’s private hospital has invested significantly in the hospital’s radiation therapy treatment center with the installation of C-RAD Catalyst HD™ and Sentinel 4DCT™ systems. The hospital and its patients are the first in Ireland to benefit from C-RAD’s advanced surface tracking systems. The order has a total value of more than 2.5 MSEK. The Catalyst HD™ will be delivered with the complete software configuration containing modules for Respiratory Gating, Patient Setup and Positioning, and Motion Monitoring. The systems have full integration with the linear accelerator. Through dedicated interfaces the C-RAD system can control the treatment beam in dependency of respiratory motion. The customer also selected C-RAD’s unique audio-visual couching functionality, which supports an interactive gating mode. Delivery and installation of the order is scheduled for December 2016. The installation is expected to go clinical early in 2017. St. Vincent’s Private Hospital is a registered charity and a not-for-profit organization. The hospital is a member of St. Vincent’s Healthcare Group, based in Dublin. In the UK and Ireland C-RAD is represented by the company Vertec Scientific Ltd. The Catalyst HD™ and Sentinel™ systems enable the high-end treatment techniques within radiation therapy that are increasingly common. With this dual solution C-RAD supports the whole 4D treatment chain from imaging to treatment delivery. Respiratory gated treatments are frequently used when the target volume is close to cardiac tissue, or for special treatments in which the tumor position depends on the respiratory cycle. “St Vincent’s Private Hospital is at the forefront in delivering comprehensive multidisciplinary oncology services to patients from across Ireland. We are committed to delivering the best quality of care to our patients. This new investment in our Radiotherapy Department will ensure we continue to improve patient care in our hospital”. “Patients will benefit for the advanced treatment techniques supported by the cutting edge C-RAD systems.” says Tim Thurn, CEO of C-RAD. “We welcome the team at St. Vincent’s Private Hospital to the growing group of C-RAD users. I am very pleased that C-RAD can contribute to improved patient care in Dublin and in the world.” C-RAD develops innovative solutions for use in advanced radiation therapy. The C-RAD group offers products and solutions for patient positioning, tumor localization and radiation treatment systems. All product development is conducted in three fully owned subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB and C-RAD Innovation AB, all of which are located in Uppsala, Sweden. C-RAD has established three companies for direct sales: C-RAD Inc. in the US, C-RAD GmbH in Germany and C-RAD WOFE in China. Cyrpa International SPRL, a Franco-Belgian laser company, is a wholly owned subsidiary whose operations are integrated. C-RAD AB is listed on NASDAQ Stockholm. For more information on C-RAD, please visit www.c-rad.com This information is information that C-RAD AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 08:30 CET on November 16, 2016.
SA Scientific Ltd. | Date: 2012-12-06
News Article | December 17, 2015
Cleaver Scientific announces the introduction of a horizontal polyacrylamide gel electrophoresis (hPAGE) system developed in collaboration with the Kirkhouse Trust, an organization supporting research and education in the biological sciences. Whilst vertical systems are commonly used for polyacrylamide gel electrophoresis, this newly developed unit’s horizontal format allows for a large number of samples to be run simultaneously and combines this with the greater resolution of polyacrylamide compared with agarose. The main advantage of the system is that it is very simple to pour and cast the polyacrylamide gels which takes away some of the complexity normally associated with vertical gel casting. The model is based on the published work of Izzo et al (2006). Dr. Janice Henderson of the Kirkhouse Trust commented "We are very pleased at the successful completion of this project in conjunction with Cleaver Scientific. In the near future hPAGE units will be supplied to all the laboratories that the Kirkhouse Trust supports to further research into the improvement of food legume crops such as the common bean and cowpea using marker assisted selection (MAS). Markers based on SSRs (simple sequence repeats) have been developed with the aim of generating elite lines with resistance to pathogens/parasites. The breeding programs generate many samples requiring analysis and the Cleaver Scientific hPAGE system makes it possible to compare many samples and achieve a resolution of a 4-6 bp difference between markers which helps to distinguish between the resistant and non-resistant plants. In addition, the hPAGE unit has great flexibility as the size of the glass plate can be varied, for example a full, half or quarter plate can be used which makes it possible to run several different gel concentrations at the same time". Cleaver Scientific Ltd., +44-1788-565300., www.cleaverscientific.com
News Article | December 1, 2015
Cleaver Scientific reports on how their CleanView UV cabinet has been used to provide a sterile workspace for the preparation of RNA / DNA samples and templates. Commenting on the implementation of the CleanView UV sterilisation cabinet in their laboratories, Dr. Lydia Hunter, a research scientist at Touchlight Genetics Ltd. said "We have made good use of our UV Sterilisation Cabinet from Cleaver Scientific, which enables us to prepare our RNA and DNA samples and templates in a clean, safe and contained environment. Touchlight Genetics would highly recommend this product and Cleaver Scientific as a supplier as their customer service has been excellent. Cleaver Scientific has been extremely supportive in ensuring their product is well maintained and meets our requirements". The CleanView range of UV Sterilisation Cabinets from Cleaver Scientific, provide a sterile contained environment for the preparation and manipulation of sensitive biological samples. Acting as a low cost alternative to a clean room, powerful UV lights in the cabinet are used to denature nucleic acids in 5 to 30 minutes making them unsuitable for amplification. White light provides excellent visibility when working within the cabinet. Cleaver UV sterilisation cabinets incorporate safety features to prevent user exposure to UV light; the UV lights are timer controlled, and there are safety switches on the cabinets doors which automatically turn the UV lights off when opened. The cabinet also acts as an efficient shield from radioactive beta emissions, and can therefore be safely used with isotopes such as 32P. Cleaver Scientific Ltd, +44 1788 565300, www.cleaverscientific.com